💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Arthur J. Gallagher shares target raised to $320 by CFRA

EditorLina Guerrero
Published 07/26/2024, 02:20 PM
AJG
-

On Friday, CFRA, a research firm, increased its price target for shares of Arthur J. Gallagher & Co. (NYSE: AJG) to $320 from the previous target of $272, while maintaining a Buy rating on the stock. The adjustment follows Arthur J. Gallagher's second-quarter earnings per share (EPS) of $2.26, which exceeded both the analyst's estimate of $2.22 and the consensus estimate of $2.24. The company also reported a 14% increase in revenue and an expansion in EBITDAC margins by 100 basis points to 31.4%.

The firm's analyst cited the rationale behind the price target increase, attributing it to the valuation of AJG shares at 24.8 times the newly initiated 2026 EPS estimate of $12.90 and at 27.9 times the 2025 EPS estimate of $11.45. These valuations compare to a three-year average forward multiple of 24 times and a peer average of 28 times. Additionally, the analyst slightly adjusted the 2024 EPS estimate upwards by $0.05 to $10.20.

Arthur J. Gallagher's performance was noted to be underpinned by robust insurance pricing and demand, with the management indicating that insurer clients are seeking rate hikes across various lines of business and regions. This "rational" behavior by insurers is seen as a positive for the company.

The research firm also revised its 2024 revenue growth forecast for Arthur J. Gallagher to a range of 14%-16%, a slight decrease from the previous 15%-20% estimate. However, the projected revenue growth for 2025 is anticipated to be between 12%-18%, which is above the growth rates of peers. The analyst views Arthur J. Gallagher as a "pure play" opportunity to benefit from a firm insurance pricing environment without the risks associated with claim cost exposure.

In other recent news, Arthur J. Gallagher & Co showcased a strong Q2 performance, with a 14% increase in revenue across its Brokerage and Risk Management segments. This growth was reinforced by the completion of twelve new mergers, projected to contribute approximately $72 million in annual revenue. The company also experienced significant margin expansions, with net earnings margin and adjusted EBITDAC margin showing considerable increases.

RBC Capital Markets has revised its price target on Arthur J. Gallagher's shares, raising it to $310 from the previous $290, while maintaining its Outperform rating. The adjustment was influenced by the company's Q2 performance, which displayed healthy organic growth across various segments. RBC Capital Markets also anticipates Arthur J. Gallagher to maintain an active stance on the mergers and acquisitions front, extending into 2025.

InvestingPro Insights

Supporting CFRA's positive outlook on Arthur J. Gallagher & Co. (NYSE: AJG), real-time data from InvestingPro shows a company with robust financial health and a strong market position. With a market capitalization of $61.69 billion and a significant revenue growth of 18.67% over the last twelve months as of Q1 2023, AJG demonstrates its ability to expand in a competitive market. Despite a high P/E ratio of 54.61, the company's consistent dividend growth, with a 9.09% increase in dividends in the last twelve months and a history of raising dividends for 40 consecutive years, reflects a commitment to shareholder returns. Moreover, AJG's price is hovering near its 52-week high, showcasing investor confidence.

InvestingPro Tips highlight AJG's expected net income growth this year and a strong return of 17.31% over the last three months, which may interest investors looking for companies with positive momentum. Additionally, out of the 12 tips available on InvestingPro, two particularly stand out: AJG has maintained dividend payments for 40 consecutive years, and analysts predict the company will be profitable this year. These insights, along with additional tips, can be accessed through InvestingPro, and for those looking to delve deeper, use coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.